Skip to content

Lucid Diagnostics LUCD Q4 2024 Annual earnings

Reported March 24, 2025 · Before market open

Revenue estimate$1.3M
EPS estimate-$0.15

Next report

Aug 12, 2026 (in a month)
Revenue estimate$1.4M
EPS estimate-$0.04

Financials

Q4 2024

Income statement

See full
Revenue$1.2M+15.1%
Gross profit-$688.3K
Operating income-$12.4M-8.1%
Net income-$11.5M-6.6%
EPS (diluted)-$0.18+28.0%

Balance sheet

See full
Cash & equivalents$22.4M+18.3%
Total debt$2.7M+103%
Total equity$5.4M+333%
Total assets$30.7M+12.6%

Cash flow

See full
Operating cash flow-$9.9M+1.1%
CapEx$74.0K
Free cash flow-$11.1M

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$48.58M-18.6%
Enterprise value$28.88M-31.4%
P/S11.2×-13.4×

Profitability

See full
Gross margin-63.3%
Operating margin-1,059.7%-338pp
Net margin-1,047.6%-357pp
FCF margin-1,022.5%

Returns & leverage

See full
Debt / equity0.5×
Current ratio1.1×+0.3×

Versus estimates

Ask the moment Lucid Diagnostics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lucid Diagnostics report Q4 2024 earnings?
Lucid Diagnostics (LUCD) reported Q4 2024 earnings on March 24, 2025 before market open.
What were Lucid Diagnostics's Q4 2024 revenue and EPS?
Lucid Diagnostics reported revenue of $1.2M and diluted EPS of $-0.19 for Q4 2024.
Did Lucid Diagnostics beat estimates in Q4 2024?
Revenue missed the consensus estimate of $1.3M by $53.0K. EPS missed the consensus estimate of $-0.15 by $0.04.
Where can I find Lucid Diagnostics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641172-25-000205) directly on SEC EDGAR. The filing index links above go to sec.gov.